Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses
Phase of Trial: Phase II
Latest Information Update: 19 Dec 2017
At a glance
- Drugs Celecoxib (Primary)
- Indications Breast cancer
- Focus Pharmacodynamics
- 12 Dec 2017 Status changed from not yet recruiting to recruiting.
- 06 Sep 2017 Planned initiation date changed from 30 Jun 2017 to 30 Oct 2017.
- 19 Jun 2017 New trial record